Granuloma
Granuloma
Explore linked clinical trials. Standard reference: MESH:M000960533 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Natural History of Injectable Permanent Synthetic Filler Disease | Foreign Bodies, Foreign-Body Reaction, Granuloma, Granuloma, Foreign-Body, Pathologic Processes, Pathological Conditions, Signs and Symptoms, injury | Recruiting | Not stated | 2026-10-09 | NCT07867353 | |
| Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes | Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Granuloma, Hemic and Lymphatic Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, chronic granulomatous disease, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, leukocyte disorder, lymphatic system disorder, lymphoproliferative syndrome, phagocyte bactericidal dysfunction | Recruiting | Not stated | 2026-10-08 | NCT00001405 | |
| A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations | Granuloma, Hemic and Lymphatic Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell non-Hodgkin lymphoma, anaplastic large cell lymphoma, astrocytoma (excluding glioblastoma), connective tissue neoplasm, epithelial neoplasm, glioblastoma, glioma, immune system disorder, immunoproliferative disorder, inflammatory myofibroblastic tumor, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor, sarcoma, solitary fibrous tumor | Recruiting | Phase 1 / Phase 2 | 2026-09-25 | NCT04094610 | |
| Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment | Eosinophilia, Granuloma, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, asthma, autoimmune disease, bronchial disorder, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, obstructive lung disease, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-09-22 | NCT07444567 | |
| The GranStone Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Foreign Bodies, Foreign-Body Reaction, Granuloma, Granuloma, Foreign-Body, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hypercalcemia disease, injury, kidney disorder, metabolic disease, nephrocalcinosis, nephrolithiasis, urinary system disorder, urolithiasis | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-18 | NCT07828002 | |
| A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-09-18 | NCT06512883 | |
| Benralizumab Effectiveness in EGPA | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not stated | 2026-09-11 | NCT07815886 | |
| Prospective Stage-Stratified Histopathologic Study and Proposed Disease-Evolution Model of Gluteal Permanent Synthetic Filler Complications | Fat Necrosis, Fibrosis, Foreign Bodies, Foreign-Body Reaction, Granuloma, Granuloma, Foreign-Body, Inflammation, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, injury | Not yet recruiting | Not stated | 2026-09-09 | NCT07808970 | |
| Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not stated | 2026-08-28 | NCT00315380 | |
| Ex Vivo Thermal Damage Assessment During Electrocautery Cutting of Explanted Biopolymer-Infiltrated Tissue | Foreign Bodies, Foreign-Body Reaction, Granuloma, Granuloma, Foreign-Body, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, injury | Not yet recruiting | Not stated | 2026-08-14 | NCT07765576 | |
| Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab. | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 3 | 2026-08-12 | NCT04157348 | |
| Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 3 | 2026-07-08 | NCT05263934 | |
| Ocular Manifestations of Granulomatosis With Polyangiitis. | Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not stated | 2026-06-24 | NCT07664709 | |
| Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 2 | 2026-05-26 | NCT06046222 | |
| Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis | Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Active, not recruiting | Phase 2 | 2026-04-29 | NCT06230354 | |
| Crizotinib Continuation Clinical Study | Granuloma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell non-Hodgkin lymphoma, Thoracic Neoplasms, anaplastic large cell lymphoma, bronchial neoplasm, bronchogenic carcinoma, immune system disorder, immunoproliferative disorder, inflammatory myofibroblastic tumor, lung disorder, lung neoplasm, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 4 | 2026-03-30 | NCT05160922 | |
| MoMa Signature During Granulomatosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Granuloma, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, gram-positive bacterial infections, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, mycobacterial infectious disease, sarcoidosis, tuberculosis | Recruiting | Not stated | 2026-03-03 | NCT05916638 | |
| Vasculitis Pregnancy Registry | Aortic Arch Syndromes, Behcet disease, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryoglobulinemic vasculitis, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Takayasu arteritis, anterior uveitis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, arteritis, autoimmune disease, autoimmune disorder of the nervous system, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, eye disorder, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, mouth disorder, necrotizing vasculitis, nervous system disorder, panuveitis, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, type III hypersensitivity disease, uveal disorder, uveitis, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-23 | NCT02593565 | |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) | Cerebral Small Vessel Diseases, Cryoglobulinemic vasculitis, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arteritis, autoimmune disease, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, drug-induced vasculitis, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT03004326 | |
| VCRC Tissue Repository | Aortic Arch Syndromes, Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Takayasu arteritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, aortitis, arteritis, autoimmune disease, autoimmune disorder of the nervous system, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, cutaneous vasculitis, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, temporal arteritis, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT02967068 | |
| One-Time DNA Study for Vasculitis | Aortic Arch Syndromes, Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, Takayasu arteritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, arteritis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, respiratory system disorder, skin disorder, skin vascular disease, temporal arteritis, vascular disorder, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT01241305 | |
| Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA | Eosinophilia, Granuloma, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, asthma, autoimmune disease, bronchial disorder, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Enrolling by invitation | Phase 4 | 2026-01-15 | NCT07343661 | |
| Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children | Food Intolerance, Granuloma, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, lymphatic system disorder, lymphoproliferative syndrome | Recruiting | Not applicable | 2025-12-24 | NCT07300865 | |
| The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome | Eosinophilia, Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not applicable | 2025-12-10 | NCT07275190 | |
| Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors | ALK-positive anaplastic large cell lymphoma, Granuloma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell non-Hodgkin lymphoma, anaplastic large cell lymphoma, immune system disorder, immunoproliferative disorder, inflammatory myofibroblastic tumor, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-12-05 | NCT04925609 |